Experimental Cutaneous Pathology Core
实验皮肤病理学核心
基本信息
- 批准号:8926360
- 负责人:
- 金额:$ 8.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Advanced DevelopmentAgeAnatomyAnimalsCell Culture TechniquesCollaborationsCommunitiesComplexComputer softwareConsultationsCore FacilityCutaneousDermatologyDermatopathologyDiagnosticEconomicsEquipmentEthnic OriginExperimental PathologyFeasibility StudiesFluorescenceFluorescence MicroscopyFosteringFreezingFundingGenderGene ExpressionGoalsHandHistologicHospitalsHumanImageIn SituInstitutional Review BoardsLaboratoriesMicroscopicMolecularMorbidity - disease rateMorphologyOperative Surgical ProceduresOrganParaffin EmbeddingPathologyPopulationPreparationProcessProtocols documentationResearchResearch PersonnelResource SharingResourcesRodentSamplingServicesSkinSpecimenTechniquesTechnologyTissue BankingTissue BanksTrainingUniversitiesWisconsinWood materialWorkcost effectiveexperienceinstrumentationinterestmembermortalityskin disordersocioeconomics
项目摘要
The overall goal of the Experimental Cutaneous Pathology Core (ECPC) is to promote cutaneous research by providing UWSDRC members with carefully processed normal and diseased human skin samples, and expertise for morphologic analysis of human and animal skin, in a cost effective manner. Dr. Jack Longley (the ECPC Director) directs the UW Dermatopathology Laboratory, which is integrated with the main Mohs Surgical Laboratory. These labs are functionally integrated with the UW Dermatology lmmunodiagnostics Laboratory, directed by Dr. Gary Wood (UWSDRC Director and ECPC Co-Director). Dr. Longley holds an IRB protocol allowing provision of de-identified normal and diseased, paraffin embedded and frozen human skin from all three laboratories for feasibility or proof of principle studies without the need for separate IRB approval. ECPC funding will be leveraged by 1) supplemental funds from the Dean and department; 2) the provision of newly renovated dedicated ECPC space contiguous with the Dermatology research labs and the UWSDRC Evolving Technology and Cell Culture Cores; and 3) new enlarged Dermatopathology Laboratory space including freezers for tissue banking provided by the UW Hospital. The ECPC will further leverage resources with several existing UW core facilities, most notably the animal Experimental Pathology Lab (EPL) managed by Dr. Ruth Sullivan, also an ECPC Co-Director. Through the EPL, the ECPC will provide sample processing by technicians with experience and special interest in routine and advanced techniques for animal skin. Together, Dr. Longley and Dr. Sullivan will provide consultation and diagnostic interpretation for experimental animal skin with an emphasis on rodent skin. The ECPC will provide UWSDRC researchers with cost effective access to and assistance with relevant equipment and all these services, and will use institutional matching funds to acquire state-of-the-art inForm software and training for in situ quantitative studies, simultaneously using multi-spectral bright field and fluorescence microscopy. The ECPC will foster the development of advanced multi-core techniques, the exchange of ideas, and collaborations among SDRC researchers by providing a centralized hub for interactions and sharing of resources related to the pathology of skin disease.
实验性皮肤病理学核心(ECPC)的总体目标是通过为UWSDRC成员提供精心处理的正常和患病的人皮肤样本,并以成本效益的方式为人类和动物皮肤的形态分析提供专业知识。杰克·朗利(Jack Longley)(ECPC主任)指挥UW皮肤病理学实验室,该实验室与主要MOHS手术实验室集成在一起。这些实验室在功能上与UW皮肤病学LMMUNOD诊断实验室(UWSDRC主管兼ECPC联合导演)指导的UW皮肤病学LMMUNODIANODNOSTICS实验室。 Longley博士持有IRB方案,允许提供从所有三个实验室中提供去识别的正常和患病,石蜡嵌入和冷冻的人类皮肤,以提供可行性或原则研究证明,而无需单独批准IRB。 ECPC的资金将由1)院长和部门的补充资金杠杆化; 2)提供与皮肤科研究实验室和UWSDRC不断发展的技术和细胞培养核的新近翻新的专用ECPC空间相连; 3)新的扩大的皮肤病理学实验室空间,包括UW医院提供的组织库的冰柜。 ECPC将通过几个现有的UW核心设施进一步利用资源,最著名的是由ECPC共同导演Ruth Sullivan博士管理的动物实验病理实验室(EPL)。通过EPL,ECPC将为技术人员提供对动物皮肤常规和先进技术的特殊兴趣的样品处理。 Longley博士和Sullivan博士一起将为实验性动物皮肤提供咨询和诊断解释,重点是啮齿动物皮肤。 ECPC将为UWSDRC研究人员提供具有成本效益的相关设备和所有这些服务的帮助,并将使用机构匹配的资金来获取最先进的信息软件和培训,以同时使用多光谱的明亮领域和荧光显微镜,同时使用原位数量研究。 ECPC将通过为SDRC研究人员之间的高级多核技术,思想的交流以及合作的开发,通过为相互作用和共享与皮肤病病理学相关的资源提供集中式枢纽。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
B Jack Longley其他文献
B Jack Longley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('B Jack Longley', 18)}}的其他基金
Epigenetic Control of Melanoma by MAGE Transcription Factors
MAGE 转录因子对黑色素瘤的表观遗传控制
- 批准号:
9241735 - 财政年份:2017
- 资助金额:
$ 8.51万 - 项目类别:
Epigenetic Control of Melanoma by MAGE Transcription Factors
MAGE 转录因子对黑色素瘤的表观遗传控制
- 批准号:
9898234 - 财政年份:2017
- 资助金额:
$ 8.51万 - 项目类别:
The Cutaneous Biology of MAGE Transcription Factors
MAGE 转录因子的皮肤生物学
- 批准号:
8385968 - 财政年份:2012
- 资助金额:
$ 8.51万 - 项目类别:
The Cutaneous Biology of MAGE Transcription Factors
MAGE 转录因子的皮肤生物学
- 批准号:
8497632 - 财政年份:2012
- 资助金额:
$ 8.51万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Retinal Determinants of Circadian Function and Sleep-Wake Cycles in Parkinson's Disease
帕金森病昼夜节律功能和睡眠-觉醒周期的视网膜决定因素
- 批准号:
10735341 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Gene Therapy that Systemically Produces Brain-penetrating Replacement Enzyme for MPS IIIA (Sanfilippo A Syndrome)
系统性产生 MPS IIIA(桑菲利波 A 综合征)的脑穿透替代酶的基因疗法
- 批准号:
10760336 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Developmental Origins of Cardiovascular Disease in Offspring from Non-Human Primate Pregnancies at Advanced Maternal Age
高龄非人类灵长类动物妊娠后代心血管疾病的发育起源
- 批准号:
10629732 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别:
Imaging Iron-Rich Pathology to Monitor and Diagnose FLTD Subtypes
对富铁病理学进行成像以监测和诊断 FLTD 亚型
- 批准号:
10591031 - 财政年份:2023
- 资助金额:
$ 8.51万 - 项目类别: